Axa’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-13,669
| Closed | -$59K | – | 1317 |
|
|
2019
Q1 | $59K | Hold |
13,669
| – | – | ﹤0.01% | 1303 |
|
|
2018
Q4 | $43K | Buy |
+13,669
| New | +$43K | ﹤0.01% | 1287 |
|
|
2018
Q2 | – | Sell |
-98,150
| Closed | -$491K | – | 1377 |
|
|
2018
Q1 | $491K | Sell |
98,150
-69,350
| -41% | -$347K | ﹤0.01% | 1164 |
|
|
2017
Q4 | $553K | Buy |
167,500
+24,000
| +17% | +$79.2K | ﹤0.01% | 1137 |
|
|
2017
Q3 | $538K | Sell |
143,500
-39,800
| -22% | -$149K | ﹤0.01% | 1092 |
|
|
2017
Q2 | $467K | Hold |
183,300
| – | – | ﹤0.01% | 1067 |
|
|
2017
Q1 | $477K | Hold |
183,300
| – | – | ﹤0.01% | 1087 |
|
|
2016
Q4 | $559K | Hold |
183,300
| – | – | ﹤0.01% | 1029 |
|
|
2016
Q3 | $499K | Buy |
183,300
+11,300
| +7% | +$30.8K | ﹤0.01% | 1025 |
|
|
2016
Q2 | $492K | Hold |
172,000
| – | – | ﹤0.01% | 1012 |
|
|
2016
Q1 | $519K | Sell |
172,000
-6,200
| -3% | -$18.7K | ﹤0.01% | 987 |
|
|
2015
Q4 | $618K | Buy |
178,200
+15,100
| +9% | +$52.4K | ﹤0.01% | 1000 |
|
|
2015
Q3 | $617K | Buy |
163,100
+37,744
| +30% | +$143K | ﹤0.01% | 1009 |
|
|
2015
Q2 | $715K | Buy |
125,356
+13,588
| +12% | +$77.5K | ﹤0.01% | 1014 |
|
|
2015
Q1 | $650K | Sell |
111,768
-5,500
| -5% | -$32K | ﹤0.01% | 1036 |
|
|
2014
Q4 | $665K | Buy |
117,268
+8,868
| +8% | +$50.3K | ﹤0.01% | 1052 |
|
|
2014
Q3 | $444K | Buy |
108,400
+5,300
| +5% | +$21.7K | ﹤0.01% | 1091 |
|
|
2014
Q2 | $469K | Hold |
103,100
| – | – | ﹤0.01% | 1092 |
|
|
2014
Q1 | $489K | Buy |
103,100
+200
| +0.2% | +$949 | ﹤0.01% | 1072 |
|
|
2013
Q4 | $484K | Sell |
102,900
-37,204
| -27% | -$175K | ﹤0.01% | 1073 |
|
|
2013
Q3 | $559K | Buy |
140,104
+26,934
| +24% | +$107K | ﹤0.01% | 977 |
|
|
2013
Q2 | $406K | Buy |
+113,170
| New | +$406K | ﹤0.01% | 1010 |
|